Live-attenuated Vaccine
Live-attenuated Vaccine - Related Videos
02:58
Generating Recombinant Live-Attenuated Influenza Viruses for Vaccines
0 Views •
2025
The video showcases a method to create cold-adapted recombinant influenza viruses. It involves transfecting human cells with bi-directional plasmids, followed by incubation at lower temperature incubation to yield viruses suitable for vaccine production, characterized by reduced replication in warmer conditions.
02:19
Intradermal Immunization with Live Attenuated Sporozoites in a Mouse Model
0 Views •
2025
This video demonstrates an assay for immunizing a mouse model with live attenuated sporozoites. The radiation-attenuated Plasmodium sporozoites are injected into the dorsal side of the mouse's ear. After injections at multiple locations on both ears, the mouse is allowed to recover.
01:51
Vaccinations
0 Views •
2019
Overview Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
08:46
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
0 Views •
Cited by 12 •
2016
We describe here a protocol for isolating myeloid cells from mouse skin and draining lymph node following intradermal injection of Plasmodium sporozoites. Flow cytometry of collected cells provides a reliable assay to characterize the skin and draining lymph node inflammatory response to the parasite.
06:17
Expression and Purification of Virus-like Particles for Vaccination
0 Views •
Cited by 27 •
2016
Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible manner.
FAQs
Limited replication allows the weakened microorganism to remain biologically active long enough to present its antigens to innate and adaptive immune systems. This activity can stimulate antibody production, T-cell responses, and immunological memory in a coordinated manner. The resulting response reflects several stages of host recognition rather than exposure to antigen alone.
Because the attenuated microorganism can undergo limited replication, its antigen exposure may more closely resemble natural infection than exposure to a nonliving preparation. That broader biological interaction can promote strong, long-lasting protection through both antibody and T-cell responses. The comparison is important when interpreting differences in immune activation and durability.
Innate immune recognition begins the response to the administered microorganism, while adaptive mechanisms develop more targeted protection. Antibodies contribute one part of this defense, and T-cell responses provide another. Together with immunological memory, these components help explain why the immune system can respond more effectively to later exposure to the relevant pathogen.
Pathogen stability is a key safety consideration because the intended protective behavior depends on the attenuated microorganism retaining its weakened characteristics. Assessment therefore considers not only whether the vaccine can stimulate immunity, but also whether the pathogen remains appropriately attenuated. This issue connects vaccine evaluation with broader questions about host-pathogen interactions and biological consistency.
Use requires careful assessment of safety and the recipient’s immune status before administration. The central concern is whether the individual can appropriately tolerate a vaccine microorganism capable of limited replication. These evaluations help distinguish situations in which the expected immune benefit is appropriate from those in which the biological behavior of the vaccine requires greater caution.
These vaccines support prevention of diseases such as measles, mumps, rubella, and yellow fever. In immunology and infection research, they also provide a system for examining how weakened pathogens interact with host defenses, stimulate antibody and T-cell responses, and generate memory. Their use therefore connects practical disease prevention with investigation of host-pathogen biology.